脊椎生物製药市场报告：2030 年趋势、预测与竞争分析

脊椎生物製药趋势与预测

到 2030 年，全球脊椎生物製药市场预计将达到 33 亿美元，2024 年至 2030 年复合年增长率为 4.5%。市场的主要驱动力是脊椎畸形盛行率的上升以及人们对微创医疗技术的认识和患者偏好的提高。全球脊椎生物製药市场的未来充满希望，医院和门诊手术中心市场充满机会。

脊椎生物製药市场洞察

Lucintel 预测，骨移植将在预测期内继续成为最大的部分，因为它减少了疾病传播的机会。

在这个市场中，医院预计将经历最高的成长。这是因为医院拥有丰富的医疗资源，包括专业部门和多学科团队，可以提供频谱的脊椎护理服务。

由于其强大的医疗保健系统、主要行业领导者的存在以及该地区对微创手术的认识和愿望不断增强，预计北美在预测期内将出现最高的增长。

常问问题

Q1.市场规模有多大？

A1. 到 2030 年，全球脊椎生物製药市场预计将达到 33 亿美元。

Q2.市场成长预测如何？

A2. 2024年至2030年，全球脊椎生物製药市场预计将以4.5%的复合年增长率成长。

Q3.影响市场成长的主要驱动因素有哪些？

A3. 该市场的主要驱动力是脊椎畸形盛行率的上升以及人们对微创医疗技术的认识和患者偏好的提高。

Q4.市场的主要细分市场是什么？

A4. 脊椎生物製药市场前景广阔，医院和门诊手术中心市场充满机会。

Q5.市场上主要企业有哪些？

A5. 生产脊椎生物製药的主要企业如下。

• Zimmer Biomet Holdings
• Johnson and Johnson
• Orthofix Medical
• Stryker
• Arthrex
• Medtronic
• K2M
• Exactech
• Wright Medical Technology
• Nuvasive

Q6.未来最大的细分市场是什么？

A6.Lucintel 预测，骨移植在预测期内仍将是最大的部分，因为它减少了疾病传播的机会。

Q7. 未来五年预计哪个地区将成为最大的市场？

A7. 由于其强大的医疗保健系统、主要行业领导者的存在以及该地区对微创手术的认识和愿望不断增强，预计北美在预测期内将呈现最高的增长。

Q8. 可以客製化报告吗？

A8. 是的，Lucintel 提供 10% 的客製化服务，无需额外付费。

目录

第一章执行摘要

第二章全球脊椎生物製药市场：市场动态

• 简介、背景、分类
• 供应链
• 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

• 宏观经济趋势（2018-2023）与预测（2024-2030）
• 全球脊椎生技药品市场趋势（2018-2023）与预测（2024-2030）
• 全球脊椎生物製药市场，依产品
  • 骨移植
  • 骨移植替代物
  • 富含血小板的血浆
  • 骨髓抽吸治疗
  • 其他的
• 全球脊椎生物製药市场（按材料）
  • 前路颈切除术融合术
  • 后路椎间融合
  • 椎间椎间融合融合术
  • 前路腰椎椎间融合
  • 侧方腰椎身体固定
• 全球脊椎生技药品市场（依最终用途产业）
  • 医院
  • 门诊外科
  • 其他的

第四章 2018-2030年区域市场趋势及预测分析

• 全球脊椎生技药品市场区域分布
• 北美脊椎生技药品市场
• 欧洲脊椎生技药品市场
• 亚太地区脊椎生技药品市场
• 其他地区脊椎生技药品市场

第五章 竞争分析

• 产品系列分析
• 营运整合
• 波特五力分析

第六章 成长机会与策略分析

• 成长机会分析
  • 全球脊椎生物製药市场成长机会（按产品）
  • 全球脊椎生物製药市场成长机会（按材料）
  • 最终用途产业的全球脊椎生技药品市场成长机会
  • 按地区分類的全球脊椎生物製药市场成长机会
• 全球脊椎生物製药市场的新兴趋势
• 战略分析
  • 新产品开发
  • 全球脊椎生技药品市场的产能扩张
  • 全球脊椎生物製药市场的合併、收购和合资企业
  • 认证和许可

第七章主要企业概况

• Zimmer Biomet Holdings
• Johnson and Johnson
• Orthofix Medical
• Stryker
• Arthrex
• Medtronic
• K2M
• Exactech
• Wright Medical Technology
• Nuvasive

Spine Biologic Trends and Forecast

The future of the global spine biologic market looks promising with opportunities in the hospitals and ambulatory surgical centres markets. The global spine biologic market is expected to reach an estimated $3.3 billion by 2030 with a CAGR of 4.5% from 2024 to 2030. The major drivers for this market are rising incidence of spinal deformities and growing recognition and patient inclination toward less invasive medical techniques.

A more than 150-page report is developed to help in your business decisions.

Spine Biologic by Segment

The study includes a forecast for the global spine biologic by product, material, end use industry, and region.

Spine Biologic Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Bone Grafts
• Bone Graft Substitutes
• Platelet-Rich Plasma
• Bone Marrow Aspirate Therapy
• Others

Spine Biologic Market by Material [Shipment Analysis by Value from 2018 to 2030]:

• Anterior Cervical Discectomy & Fusion
• Posterior Lumbar Interbody Fusion
• Transforaminal Lumbar Interbody Fusion
• Anterior Lumbar Interbody Fusion
• Lateral Lumbar Interbody Fusion

Spine Biologic Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

• Hospital
• Ambulatory Surgical
• Others

Spine Biologic Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Spine Biologic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies spine biologic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the spine biologic companies profiled in this report include-

• Zimmer Biomet Holdings
• Johnson and Johnson
• Orthofix Medical
• Stryker
• Arthrex
• Medtronic
• K2M
• Exactech
• Wright Medical Technology
• Nuvasive

Spine Biologic Market Insights

Lucintel forecasts that bone graft will remain the largest segment over the forecast period due to it lowers the chances of disease transmission.

Within this market, hospital is expected to witness the highest growth due to they are furnished with extensive healthcare resources, encompassing specialized divisions and interdisciplinary teams capable of delivering a complete spectrum of spinal care services.

North America is expected to witness highest growth over the forecast period due to robust healthcare system, the presence of key industry leaders, and a growing awareness and desire for minimally invasive procedures in this region.

Features of the Global Spine Biologic Market

Market Size Estimates: Spine biologic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Spine biologic market size by product, material, end use industry, and region in terms of value ($B).

Regional Analysis: Spine biologic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product, material, end use industry, and regions for the spine biologic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the spine biologic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the spine biologic market size?

Answer: The global spine biologic market is expected to reach an estimated $3.3 billion by 2030.

Q2. What is the growth forecast for spine biologic market?

Answer: The global spine biologic market is expected to grow with a CAGR of 4.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the spine biologic market?

Answer: The major drivers for this market are rising incidence of spinal deformities and growing recognition and patient inclination toward less invasive medical techniques.

Q4. What are the major segments for spine biologic market?

Answer: The future of the spine biologic market looks promising with opportunities in the hospitals and ambulatory surgical centres markets.

Q5. Who are the key spine biologic market companies?

Answer: Some of the key spine biologic companies are as follows.

• Zimmer Biomet Holdings
• Johnson and Johnson
• Orthofix Medical
• Stryker
• Arthrex
• Medtronic
• K2M
• Exactech
• Wright Medical Technology
• Nuvasive

Q6. Which spine biologic market segment will be the largest in future?

Answer: Lucintel forecasts that bone graft will remain the largest segment over the forecast period due to it lowers the chances of disease transmission.

Q7. In spine biologic market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to robust healthcare system, the presence of key industry leaders, and a growing awareness and desire for minimally invasive procedures in this region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the spine biologic market by product (bone grafts, bone graft substitutes, platelet-rich plasma, bone marrow aspirate therapy, and others), material (anterior cervical discectomy & fusion, posterior lumbar interbody fusion, transforaminal lumbar interbody fusion, anterior lumbar interbody fusion, and lateral lumbar interbody fusion), end use industry (hospital, ambulatory surgical, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Spine Biologic Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Spine Biologic Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Spine Biologic Market by Product
  • 3.3.1: Bone Grafts
  • 3.3.2: Bone Graft Substitutes
  • 3.3.3: Platelet-Rich Plasma
  • 3.3.4: Bone Marrow Aspirate Therapy
  • 3.3.5: Others
• 3.4: Global Spine Biologic Market by Material
  • 3.4.1: Anterior Cervical Discectomy & Fusion
  • 3.4.2: Posterior Lumbar Interbody Fusion
  • 3.4.3: Transforaminal Lumbar Interbody Fusion
  • 3.4.4: Anterior Lumbar Interbody Fusion
  • 3.4.5: Lateral Lumbar Interbody Fusion
• 3.5: Global Spine Biologic Market by End Use Industry
  • 3.5.1: Hospital
  • 3.5.2: Ambulatory Surgical
  • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Spine Biologic Market by Region
• 4.2: North American Spine Biologic Market
  • 4.2.2: North American Spine Biologic Market by End Use Industry: Hospital, Ambulatory Surgical, and Others
• 4.3: European Spine Biologic Market
  • 4.3.1: European Spine Biologic Market by Product: Bone Grafts, Bone Graft Substitutes, Platelet-Rich Plasma, Bone Marrow Aspirate Therapy, and Others
  • 4.3.2: European Spine Biologic Market by End Use Industry: Hospital, Ambulatory Surgical, and Others
• 4.4: APAC Spine Biologic Market
  • 4.4.1: APAC Spine Biologic Market by Product: Bone Grafts, Bone Graft Substitutes, Platelet-Rich Plasma, Bone Marrow Aspirate Therapy, and Others
  • 4.4.2: APAC Spine Biologic Market by End Use Industry: Hospital, Ambulatory Surgical, and Others
• 4.5: ROW Spine Biologic Market
  • 4.5.1: ROW Spine Biologic Market by Product: Bone Grafts, Bone Graft Substitutes, Platelet-Rich Plasma, Bone Marrow Aspirate Therapy, and Others
  • 4.5.2: ROW Spine Biologic Market by End Use Industry: Hospital, Ambulatory Surgical, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Spine Biologic Market by Product
  • 6.1.2: Growth Opportunities for the Global Spine Biologic Market by Material
  • 6.1.3: Growth Opportunities for the Global Spine Biologic Market by End Use Industry
  • 6.1.4: Growth Opportunities for the Global Spine Biologic Market by Region
• 6.2: Emerging Trends in the Global Spine Biologic Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Spine Biologic Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Spine Biologic Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Zimmer Biomet Holdings
• 7.2: Johnson and Johnson
• 7.3: Orthofix Medical
• 7.4: Stryker
• 7.5: Arthrex
• 7.6: Medtronic
• 7.7: K2M
• 7.8: Exactech
• 7.9: Wright Medical Technology
• 7.10: Nuvasive